Suppr超能文献

印度亚临床和显性维生素D过多症日益严重的问题:一项机构经验与综述。

The increasing problem of subclinical and overt hypervitaminosis D in India: An institutional experience and review.

作者信息

Sharma Lokesh Kumar, Dutta Deep, Sharma Neera, Gadpayle Adesh Kisanji

机构信息

Department of Biochemistry, Post Graduate Institute of Medical Education & Research (PGIMER) and Dr. Ram Manohar Lohia (RML) Hospital, New Delhi, India.

Department of Endocrinology, Post Graduate Institute of Medical Education & Research (PGIMER) and Dr. Ram Manohar Lohia (RML) Hospital, New Delhi, India.

出版信息

Nutrition. 2017 Feb;34:76-81. doi: 10.1016/j.nut.2016.09.014. Epub 2016 Oct 6.

Abstract

OBJECTIVE

The aim of this study was to determine the changes in serum vitamin D distribution at an institute in India over the past 6 y and compare it with global trends.

METHODS

We conducted an audit of 25-hydroxyvitamin D (25-OHD), calcium, and plasma intact parathyroid hormone (iPTH) reporting from January 2011 to February 2016. References for review were identified through searches of PubMed, Medline, and Embase for articles published until February 2016 using keywords "hypervitaminosis D" (MeSH Terms) OR "vitamin D toxicity" (All Fields) OR "vitamin-D intoxication" (All Fields).

RESULTS

Reports of 25-OHD from 5527 patients were analyzed. Calcium and iPTH were available for 5501 (99.5%) and 1787 (32.3%) patients, respectively. Vitamin D deficiency and insufficiency were observed in 59.4 and 77.3%. Hypervitaminosis D (25-OHD >250 nmol/L) was noted in 225 (4.1%) patients, of whom 151 (2.7%) had vitamin D intoxication (25-OHD >375 nmol/L). We found that 46.22% (104 of 225) patients with hypervitaminosis D and 62.25% (94 of 151) with vitamin D intoxication had elevated calcium or suppressed iPTH. Orthopedic, pediatric, and surgery patients had the highest rates of hypervitaminosis D (7.9, 7.2, and 7% respectively; P < 0.001). An increasing trend for hypervitaminosis D was observed (1.48, 3.62, 3.90, 4.78, 6.21, and 7.82% in 2011, 2012, 2013, 2014, 2015, and 2016, respectively). A similar steady upward trend in 25-OHD has been reported in Ireland, England, Canada, and Australia. However, hypervitaminosis D reports are scant and have not increased over the years in the developed world.

CONCLUSION

There is a global secular trend of increases in 25-OHD over years. There is a disturbing trend of increased hypervitaminosis D at an Indian institute. Empiric, unmonitored, prolonged vitamin D supplementation, using non-recommended supraphysiological doses, especially when administered intramuscularly, should be discouraged.

摘要

目的

本研究旨在确定印度某机构过去6年血清维生素D分布的变化,并将其与全球趋势进行比较。

方法

我们对2011年1月至2016年2月期间25-羟维生素D(25-OHD)、钙和血浆完整甲状旁腺激素(iPTH)的报告进行了审核。通过搜索PubMed、Medline和Embase,使用关键词“维生素D过多症”(医学主题词)或“维生素D毒性”(所有字段)或“维生素D中毒”(所有字段),查找截至2016年2月发表的文章作为综述参考文献。

结果

分析了5527例患者的25-OHD报告。分别有5501例(99.5%)和1787例(32.3%)患者有钙和iPTH数据。维生素D缺乏和不足的发生率分别为59.4%和77.3%。225例(4.1%)患者出现维生素D过多症(25-OHD>250 nmol/L),其中151例(2.7%)出现维生素D中毒(25-OHD>375 nmol/L)。我们发现,46.22%(225例中的104例)维生素D过多症患者和62.25%(151例中的94例)维生素D中毒患者的钙升高或iPTH受抑制。骨科、儿科和外科患者的维生素D过多症发生率最高(分别为7.9%、7.2%和7%;P<0.001)。观察到维生素D过多症呈上升趋势(2011年、2012年、2013年、2014年、2015年和2016年分别为1.48%、3.62%、3.90%、4.78%、6.21%和7.82%)。爱尔兰、英国、加拿大和澳大利亚也报告了25-OHD类似的稳定上升趋势。然而,在发达国家,维生素D过多症的报告很少,且多年来没有增加。

结论

多年来全球25-OHD呈长期上升趋势。印度某机构出现维生素D过多症增加的不良趋势。应避免经验性、无监测地长期补充维生素D,使用非推荐的超生理剂量,尤其是肌肉注射时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验